Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Kimberly Page, PhD, MPH

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentEpidemiology & Biostatistics
    Address50 Beale Street
    San Francisco CA 94143
    Phone415-597-4954

       Overview 
       Overview
      Dr. Page is a Professor in Residence in the Department of Epidemiology and Biostatistics, Division of Infectious Disease, in the Department of Medicine at University of California San Francisco (UCSF). She is located with the Global Health Sciences group. She holds joint appointments in the Department of Medicine, Center for AIDS Prevention Studies (CAPS), in the Department of Orofacial Sciences in the School of Dentistry at UCSF and at the San Francisco Veteran's Administration Medical Center (SFVAMC) Department of Medicine, Division of Gastroenterology. She received her Ph.D and MPH from the University of California at Berkeley and completed fellowships at the UCSF Center for AIDS Prevention Studies and the Municipal Health Service in Amsterdam, the Netherlands. She has been the PI of multiple NIH and CDC funded grants, and collaborates with researchers nationally and internationally. Dr. Page is an infectious disease epidemiologist; her research is principally focused on HIV and hepatitis C virus (HCV) infections, principally prevention, natural history, and intervention research in marginalized and underserved populations including injection drug users, and female sex workers. She is currently leading a clinical trial testing a prophylactic HCV vaccine in active injection drug users and a large implementation science trial in Cambodia to reduce drug use and HIV infection in female sex workers. She is the PI of two NIH NIDA funded studies of of HIV and HCV including: the UFO Study, an internationally recognized study of acute HCV in young adult injection drug users, and, the InC3 Collaborative, which brings together investigators and data from preeminent prospective studies of HIV and HCV globally. Dr. Page has been a faculty lead, as Director of Latin and Central America Region for the Fogarty funded International Traineeships in AIDS Prevention Studies (ITAPS) program at UCSF since 2002, providing training and capacity building to scientists from developing countries including Brazil, Argentina, Peru, Guatemala, Mexico, and from Southeast Asia, including Cambodia and Thailand. To learn more about Dr. Page please visit the links below.

       Interests
      Infectious Disease epidemiology, viral hepatitis, HIV, hard-to-reach populations, vaccines, prevention science, implementation science, drug use, sex work, international public health, capacity building, ethics in human subjects research

       ORNG Applications 
       Websites
       Featured Videos
       In The News
       Featured Presentations
       Awarded Grants
       Global Health
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Silveira MP, Guttier MC, Moreira LB, Mirzazadeh A, Page K. Predictors of Non-adherence to Clinical Follow-up Among Patients Participating in a Randomized Trial of Pharmaceutical Care Intervention in HIV-Positive Adults in Southern Brazil. AIDS Behav. 2014 Jan; 18 Suppl 1:85-8.
        View in: PubMed
      2. Ikeda JM, Schaffer JR, Sac Ixcot ML, Page K, Hearst N. Risk of Sexually Transmitted Infections Among Mayan Women in Rural Guatemala Whose Partners are Migrant Workers. AIDS Behav. 2014 Jan; 18 Suppl 1:32-6.
        View in: PubMed
      3. Silveira MP, Guttier MC, Page K, Moreira LB. Randomized Controlled Trial to Evaluate the Impact of Pharmaceutical Care on Therapeutic Success in HIV-Infected Patients in Southern Brazil. AIDS Behav. 2014 Jan; 18 Suppl 1:75-84.
        View in: PubMed
      4. Callegari FM, Pinto-Neto LF, Medeiros CJ, Scopel CB, Page K, Miranda AE. Syphilis and HIV Co-Infection in Patients Who Attend an AIDS Outpatient Clinic in Vitoria, Brazil. AIDS Behav. 2014 Jan; 18 Suppl 1:104-9.
        View in: PubMed
      5. Miranda AE, Pinto VM, McFarland W, Page K. HIV Infection Among Young Pregnant Women in Brazil: Prevalence and Associated Risk Factors. AIDS Behav. 2014 Jan; 18 Suppl 1:50-2.
        View in: PubMed
      6. Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J, Morris MD, Hajarizadeh B, Amin J, Cox AL, Kim AY, McGovern BH, Schinkel J, George J, Shoukry NH, Lauer GM, Maher L, Lloyd AR, Hellard M, Dore GJ, Prins M. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014 Jan; 59(1):109-20.
        View in: PubMed
      7. Asher AK, Santos GM, Evans J, Dokubo EK, Lee TH, Martin JN, Deeks SG, Tobler LH, Busch M, Hunt PW, Page K. Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers. AIDS. 2013 Nov 13; 27(17):2691-6.
        View in: PubMed
      8. Kim AY, Page K. Hepatitis C virus serosorting in people who inject drugs: sorting out the details. J Infect Dis. 2013 Dec; 208(12):1929-31.
        View in: PubMed
      9. Page K, Stein E, Sansothy N, Evans J, Couture MC, Sichan K, Cockroft M, Mooney-Somers J, Phlong P, Kaldor J, Maher L. Sex work and HIV in Cambodia: trajectories of risk and disease in two cohorts of high-risk young women in Phnom Penh, Cambodia. BMJ Open. 2013; 3(9):e003095.
        View in: PubMed
      10. Page K, Morris MD, Hahn JA, Maher L, Prins M. Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. Clin Infect Dis. 2013 Aug; 57 Suppl 2:S32-8.
        View in: PubMed
      11. Page K, Morris MD, Hahn JA, Maher L, Prins M. Clinical Infectious Diseases. Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. 2013; S2(57):32-38.
      12. Pinto Neto LF, das Neves MB, Ribeiro-Rodrigues R, Page K, Miranda AE. Dyslipidemia and fasting glucose impairment among HIV patients three years after the first antiretroviral regimen in a Brazilian AIDS outpatient clinic. Braz J Infect Dis. 2013 Jul-Aug; 17(4):438-43.
        View in: PubMed
      13. Evans JL, Couture MC, Stein ES, Sansothy N, Maher L, Page K. Biomarker validation of recent unprotected sexual intercourse in a prospective study of young women engaged in sex work in Phnom Penh, Cambodia. Sex Transm Dis. 2013 Jun; 40(6):462-8.
        View in: PubMed
      14. Montgomery ME, Fatch RS, Evans JL, Yu M, Davidson PJ, Page K, Hahn JA. Injecting risk behavior among traveling young injection drug users: travel partner and city characteristics. J Urban Health. 2013 Jun; 90(3):500-15.
        View in: PubMed
      15. Maher L, Mooney-Somers J, Phlong P, Couture MC, Kien SP, Stein E, Bates AJ, Sansothy N, Page K. Condom negotiation across different relationship types by young women engaged in sex work in Phnom Penh, Cambodia. Glob Public Health. 2013; 8(3):270-83.
        View in: PubMed
      16. Asher AK, Hahn JA, Couture MC, Maher K, Page K. people who inject drugs, HIV risk, and HIV testing uptake in sub-Saharan Africa. J Assoc Nurses AIDS Care. 2013 Nov-Dec; 24(6):e35-44.
        View in: PubMed
      17. White B, Madden A, Hellard M, Kerr T, Prins M, Page K, Dore GJ, Maher L. Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugs. Drug Alcohol Rev. 2013 Jul; 32(4):419-25.
        View in: PubMed
      18. Page K, Osburn W, Evans J, Hahn JA, Lum P, Asher A, Delwart E, Tobler L, Cox AL, Busch MP. Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection. Clin Infect Dis. 2013 Feb; 56(3):405-13.
        View in: PubMed
      19. Brown C, Krishnan S, Hursh K, Yu M, Johnson P, Page K, Shiboski CH. Dental disease prevalence among methamphetamine and heroin users in an urban setting: a pilot study. J Am Dent Assoc. 2012 Sep; 143(9):992-1001.
        View in: PubMed
      20. Couture MC, Page K, Stein ES, Sansothy N, Sichan K, Kaldor J, Evans JL, Maher L, Palefsky J. Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection. BMC Infect Dis. 2012; 12:166.
        View in: PubMed
      21. Wang Z, Du J, Zhao M, Page K, Xiao Z, Mandel JS. Hepatitis C virus infection is independently associated with depression among methadone maintenance treatment heroin users in China. Asia Pac Psychiatry. 2013 Sep; 5(3):191-6.
        View in: PubMed
      22. Le Marchand C, Evans J, Page K, Davidson PJ, Hahn JA. Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors. Drug Alcohol Depend. 2013 Jan 1; 127(1-3):143-9.
        View in: PubMed
      23. Kab V, Evans J, Sansothy N, Stein E, Claude-Couture M, Maher L, Page K. Testing for amphetamine-type stimulant (ATS) use to ascertain validity of self-reported ATS use among young female sex workers in Cambodia. Addict Sci Clin Pract. 2012; 7(1):11.
        View in: PubMed
      24. Davidson P, Page K. Research participation as work: comparing the perspectives of researchers and economically marginalized populations. Am J Public Health. 2012 Jul; 102(7):1254-9.
        View in: PubMed
      25. Grebely J, Prins M, Hellard M, Cox AL, Osburn WO, Lauer G, Page K, Lloyd AR, Dore GJ. Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. Lancet Infect Dis. 2012 May; 12(5):408-14.
        View in: PubMed
      26. Vickerman P, Grebely J, Dore GJ, Sacks-Davis R, Page K, Thomas DL, Osburn WO, Cox AL, Aitken CK, Hickman M, Hellard M. The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design. J Infect Dis. 2012 May 1; 205(9):1342-50.
        View in: PubMed
      27. Evans JL, Tsui JI, Hahn JA, Davidson PJ, Lum PJ, Page K. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. Am J Epidemiol. 2012 Feb 15; 175(4):302-8.
        View in: PubMed
      28. Miranda AE, Figueiredo NC, Pinto VM, Page K, Talhari S. Risk factors for syphilis in young women attending a family health program in Vitória, Brazil. An Bras Dermatol. 2012 Jan-Feb; 87(1):76-83.
        View in: PubMed
      29. Maher L, Mooney-Somers J, Phlong P, Couture MC, Stein E, Evans J, Cockroft M, Sansothy N, Nemoto T, Page K. Selling sex in unsafe spaces: sex work risk environments in Phnom Penh, Cambodia. Harm Reduct J. 2011; 8(1):30.
        View in: PubMed
      30. Pinho AA, Chinaglia M, Lippman SA, Reingold A, Diaz RS, Sucupira MC, Page K, Díaz J. Prevalence and factors associated with HSV-2 and hepatitis B infections among truck drivers crossing the southern Brazilian border. Sex Transm Infect. 2011 Dec; 87(7):553-9.
        View in: PubMed
      31. Singh KM, Phung YT, Kohla MS, Lan BY, Chan S, Suen DL, Murad S, Rheault S, Davidson P, Evans J, Singh M, Dohil S, Osorio RW, Wakil AE, Page K, Feng S, Cooper SL. KIR genotypic diversity can track ancestries in heterogeneous populations: a potential confounder for disease association studies. Immunogenetics. 2012 Feb; 64(2):97-109.
        View in: PubMed
      32. Couture MC, Evans JL, Sothy NS, Stein ES, Sichan K, Maher L, Page K. Correlates of amphetamine-type stimulant use and associations with HIV-related risks among young women engaged in sex work in Phnom Penh, Cambodia. Drug Alcohol Depend. 2012 Jan 1; 120(1-3):119-26.
        View in: PubMed
      33. Dias PT, Hahn JA, Delwart E, Edlin B, Martin J, Lum P, Evans J, Kral A, Deeks S, Busch MP, Page K. Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California. BMC Infect Dis. 2011; 11:208.
        View in: PubMed
      34. Bahia F, Novais V, Evans J, Le Marchand C, Netto E, Page K, Brites C. The impact of human T-cell lymphotropic virus I infection on clinical and immunologic outcomes in patients coinfected with HIV and hepatitis C virus. J Acquir Immune Defic Syndr. 2011 Aug; 57 Suppl 3:S202-7.
        View in: PubMed
      35. Asher A, Lum PJ, Page K. Assessing candidacy for acute hepatitis C treatment among active young injection drug users: a case-series report. J Assoc Nurses AIDS Care. 2012 Jan-Feb; 23(1):16-29.
        View in: PubMed
      36. Maher L, Phlong P, Mooney-Somers J, Keo S, Stein E, Couture MC, Page K. Amphetamine-type stimulant use and HIV/STI risk behaviour among young female sex workers in Phnom Penh, Cambodia. Int J Drug Policy. 2011 May; 22(3):203-9.
        View in: PubMed
      37. Etcheverry MF, Lum PJ, Evans JL, Sanchez E, de Lazzari E, Mendez-Arancibia E, Sierra E, Gatell JM, Page K, Joseph J. HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco. Vaccine. 2011 Feb 24; 29(10):1991-6.
        View in: PubMed
      38. Couture MC, Sansothy N, Sapphon V, Phal S, Sichan K, Stein E, Evans J, Maher L, Kaldor J, Vun MC, Page K. Young women engaged in sex work in Phnom Penh, Cambodia, have high incidence of HIV and sexually transmitted infections, and amphetamine-type stimulant use: new challenges to HIV prevention and risk. Sex Transm Dis. 2011 Jan; 38(1):33-9.
        View in: PubMed
      39. Maher L, White B, Hellard M, Madden A, Prins M, Kerr T, Page K. Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities. Vaccine. 2010 Oct 21; 28(45):7273-8.
        View in: PubMed
      40. Levy V, Evans JL, Stein ES, Davidson PJ, Lum PJ, Hahn JA, Page K. Are young injection drug users ready and willing to participate in preventive HCV vaccine trials? Vaccine. 2010 Aug 23; 28(37):5947-51.
        View in: PubMed
      41. Hahn JA, Evans JL, Davidson PJ, Lum PJ, Page K. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users. Addiction. 2010 Jul; 105(7):1254-64.
        View in: PubMed
      42. Berini CA, Gendler SA, Pascuccio S, Eirin ME, McFarland W, Page K, Carnevali L, Murphy E, Biglione MM. Decreasing trends in HTLV-1/2 but stable HIV-1 infection among replacement donors in Argentina. J Med Virol. 2010 May; 82(5):873-7.
        View in: PubMed
      43. Sarang A, Rhodes T, Sheon N, Page K. Policing drug users in Russia: risk, fear, and structural violence. Subst Use Misuse. 2010 May; 45(6):813-64.
        View in: PubMed
      44. Page K, Hahn JA, Evans J, Shiboski S, Lum P, Delwart E, Tobler L, Andrews W, Avanesyan L, Cooper S, Busch MP. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis. 2009 Oct 15; 200(8):1216-26.
        View in: PubMed
      45. Miranda AE, St Louis ME, Figueiredo NC, Milbratz I, Page-Shafer K. Young women and their reproductive health needs in a family practice setting: factors influencing care seeking in Vitoria, Brazil. Fam Pract. 2009 Dec; 26(6):493-500.
        View in: PubMed
      46. Tsui JI, Vittinghoff E, Hahn JA, Evans JL, Davidson PJ, Page K. Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco. Drug Alcohol Depend. 2009 Nov 1; 105(1-2):160-3.
        View in: PubMed
      47. Levy V, Yuan J, Ruiz J, Morrow S, Reardon J, Facer M, Molitor F, Allen B, Ajufo BG, Bell-Sanford G, McFarland W, Raymond HF, Kellogg T, Page K. Hepatitis B sero-prevalence and risk behaviors among immigrant men in a population-based household survey in low-income neighborhoods of northern California. J Immigr Minor Health. 2010 Dec; 12(6):828-33.
        View in: PubMed
      48. Hahn JA, Wylie D, Dill J, Sanchez MS, Lloyd-Smith JO, Page-Shafer K, Getz WM. Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users. Epidemics. 2009 Mar; 1(1):47-57.
        View in: PubMed
      49. Evans JL, Hahn JA, Lum PJ, Stein ES, Page K. Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study). Drug Alcohol Depend. 2009 May 1; 101(3):152-7.
        View in: PubMed
      50. Cox AL, Page K, Bruneau J, Shoukry NH, Lauer GM, Kim AY, Rosen HR, Radziewicz H, Grakoui A, Fierer DS, Branch AD, Kaplan DE, Chang KM. Rare birds in North America: acute hepatitis C cohorts. Gastroenterology. 2009 Jan; 136(1):26-31.
        View in: PubMed
      51. Figueiredo NC, Page-Shafer K, Pereira FE, Miranda AE. [Serological markers for hepatitis B virus in young women attended by the Family Health Program in Vitória, Espírito Santo, 2006]. Rev Soc Bras Med Trop. 2008 Nov-Dec; 41(6):590-5.
        View in: PubMed
      52. Sampaio-Sa M, Page-Shafer K, Bangsberg DR, Evans J, Dourado Mde L, Teixeira C, Netto EM, Brites C. 100% adherence study: educational workshops vs. video sessions to improve adherence among ART-naïve patients in Salvador, Brazil. AIDS Behav. 2008 Jul; 12(4 Suppl):S54-62.
        View in: PubMed
      53. Fialho M, Messias M, Page-Shafer K, Farre L, Schmalb M, Pedral-Sampaio D, Ramos M, Brites C. Prevalence and risk of blood-borne and sexually transmitted viral infections in incarcerated youth in Salvador, Brazil: opportunity and obligation for intervention. AIDS Behav. 2008 Jul; 12(4 Suppl):S17-24.
        View in: PubMed
      54. Inglez-Dias A, Hahn JA, Lum PJ, Evans J, Davidson P, Page-Shafer K. Trends in methamphetamine use in young injection drug users in San Francisco from 1998 to 2004: the UFO Study. Drug Alcohol Rev. 2008 May; 27(3):286-91.
        View in: PubMed
      55. Miranda AE, Figueiredo NC, Schmidt R, Page-Shafer K. A population-based survey of the prevalence of HIV, syphilis, hepatitis B and hepatitis C infections, and associated risk factors among young women in Vitória, Brazil. AIDS Behav. 2008 Jul; 12(4 Suppl):S25-31.
        View in: PubMed
      56. Lum PJ, Hahn JA, Shafer KP, Evans JL, Davidson PJ, Stein E, Moss AR. Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco. J Viral Hepat. 2008 Mar; 15(3):229-36.
        View in: PubMed
      57. Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, Page-Shafer K, Hsue P, Emu B, Krone M, Lampiris H, Douek D, Martin JN, Deeks SG. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis. 2008 Jan 1; 197(1):126-33.
        View in: PubMed
      58. Page-Shafer K, Pappalardo BL, Tobler LH, Phelps BH, Edlin BR, Moss AR, Wright TL, Wright DJ, O'Brien TR, Caglioti S, Busch MP. Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. J Clin Microbiol. 2008 Feb; 46(2):499-506.
        View in: PubMed
      59. Hahn JA, Page-Shafer K, Ford J, Paciorek A, Lum PJ. Traveling young injection drug users at high risk for acquisition and transmission of viral infections. Drug Alcohol Depend. 2008 Jan 11; 93(1-2):43-50.
        View in: PubMed
      60. Page-Shafer K, Hahn JA, Lum PJ. Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough. AIDS. 2007 Sep 12; 21(14):1967-9.
        View in: PubMed
      61. Bernardin F, Stramer SL, Rehermann B, Page-Shafer K, Cooper S, Bangsberg DR, Hahn J, Tobler L, Busch M, Delwart E. High levels of subgenomic HCV plasma RNA in immunosilent infections. Virology. 2007 Sep 1; 365(2):446-56.
        View in: PubMed
      62. Sucupira MC, Caseiro MM, Alves K, Tescarollo G, Janini LM, Sabino EC, Castelo A, Page-Shafer K, Diaz RS. High levels of primary antiretroviral resistance genotypic mutations and B/F recombinants in Santos, Brazil. AIDS Patient Care STDS. 2007 Feb; 21(2):116-28.
        View in: PubMed
      63. Levy V, Prentiss D, Balmas G, Chen S, Israelski D, Katzenstein D, Page-Shafer K. Factors in the delayed HIV presentation of immigrants in Northern California: implications for voluntary counseling and testing programs. J Immigr Minor Health. 2007 Jan; 9(1):49-54.
        View in: PubMed
      64. Bernardin F, Herring B, Page-Shafer K, Kuiken C, Delwart E. Absence of HCV viral recombination following superinfection. J Viral Hepat. 2006 Aug; 13(8):532-7.
        View in: PubMed
      65. de Carvalho FT, Neiva-Silva L, Ramos MC, Evans J, Koller SH, Piccinini CA, Page-Shafer K. Sexual and drug use risk behaviors among children and youth in street circumstances in Porto Alegre, Brazil. AIDS Behav. 2006 Jul; 10(4 Suppl):S57-66.
        View in: PubMed
      66. Telles Dias PR, Souto K, Page-Shafer K. Long-term female condom use among vulnerable populations in Brazil. AIDS Behav. 2006 Jul; 10(4 Suppl):S67-75.
        View in: PubMed
      67. Bacon O, Lum P, Hahn J, Evans J, Davidson P, Moss A, Page-Shafer K. Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco. Sex Transm Dis. 2006 Apr; 33(4):228-34.
        View in: PubMed
      68. Page-Shafer K, Sweet S, Kassaye S, Ssali C. (C2) Saliva, breast milk, and mucosal fluids in HIV transmission. Adv Dent Res. 2006; 19(1):152-7.
        View in: PubMed
      69. Kim AA, Sun LP, Chhorvann C, Lindan C, Van Griensven F, Kilmarx PH, Sirivongrangson P, Louie JK, Leng HB, Page-Shafer K. High prevalence of HIV and sexually transmitted infections among indirect sex workers in Cambodia. Sex Transm Dis. 2005 Dec; 32(12):745-51.
        View in: PubMed
      70. Cohan DL, Kim A, Ruiz J, Morrow S, Reardon J, Lynch M, Klausner JD, Molitor F, Allen B, Green Ajufo B, Ferrero D, Bell Sanford G, Page-Shafer K, Delgado V, McFarland W. Health indicators among low income women who report a history of sex work: the population based Northern California Young Women's Survey. Sex Transm Infect. 2005 Oct; 81(5):428-33.
        View in: PubMed
      71. Page-Shafer K, Saphonn V, Sun LP, Vun MC, Cooper DA, Kaldor JM. HIV prevention research in a resource-limited setting: the experience of planning a trial in Cambodia. Lancet. 2005 Oct 22-28; 366(9495):1499-503.
        View in: PubMed
      72. Levy V, Page-Shafer K, Evans J, Ruiz J, Morrow S, Reardon J, Lynch M, Raymond HF, Klausner JD, Facer M, Molitor F, Allen B, Ajufo BG, Ferrero D, Sanford GB, McFarland W. HIV-related risk behavior among Hispanic immigrant men in a population-based household survey in low-income neighborhoods of northern California. Sex Transm Dis. 2005 Aug; 32(8):487-90.
        View in: PubMed
      73. Ochoa KC, Davidson PJ, Evans JL, Hahn JA, Page-Shafer K, Moss AR. Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend. 2005 Dec 12; 80(3):297-302.
        View in: PubMed
      74. Fox RK, Currie SL, Evans J, Wright TL, Tobler L, Phelps B, Busch MP, Page-Shafer KA. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis. 2005 Jul 15; 41(2):177-86.
        View in: PubMed
      75. Busch MP, Shafer KA. Acute-phase hepatitis C virus infection: implications for research, diagnosis, and treatment. Clin Infect Dis. 2005 Apr 1; 40(7):959-61.
        View in: PubMed
      76. Kral AH, Page-Shafer K, Edlin BR, Kellogg T, Riley E, Gee L, Moss A, Busch M, Klausner JD, Dilley J, McFarland W. Persistent HIV incidence among injection drug users in San Francisco during the 1990s: results of five studies. J Acquir Immune Defic Syndr. 2004 Dec 15; 37(5):1667-9.
        View in: PubMed
      77. Herring BL, Page-Shafer K, Tobler LH, Delwart EL. Frequent hepatitis C virus superinfection in injection drug users. J Infect Dis. 2004 Oct 15; 190(8):1396-403.
        View in: PubMed
      78. Miranda AE, Szwarcwald CL, Peres RL, Page-Shafer K. Prevalence and risk behaviors for chlamydial infection in a population-based study of female adolescents in Brazil. Sex Transm Dis. 2004 Sep; 31(9):542-6.
        View in: PubMed
      79. Samnang P, Leng HB, Kim A, Canchola A, Moss A, Mandel JS, Page-Shafer K. HIV prevalence and risk factors among fishermen in Sihanouk Ville, Cambodia. Int J STD AIDS. 2004 Jul; 15(7):479-83.
        View in: PubMed
      80. Karlsson RK, Jennes W, Page-Shafer K, Nixon DF, Shacklett BL. Poorly soluble peptides can mimic authentic ELISPOT responses. J Immunol Methods. 2004 Feb 1; 285(1):89-92.
        View in: PubMed
      81. Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, Grant RM, Osmond DH. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS. 2004 Jan 2; 18(1):81-8.
        View in: PubMed
      82. Hammer GP, Kellogg TA, McFarland WC, Wong E, Louie B, Williams I, Dilley J, Page-Shafer K, Klausner JD. Low incidence and prevalence of hepatitis C virus infection among sexually active non-intravenous drug-using adults, San Francisco, 1997-2000. Sex Transm Dis. 2003 Dec; 30(12):919-24.
        View in: PubMed
      83. Lum PJ, Ochoa KC, Hahn JA, Page Shafer K, Evans JL, Moss AR. Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study. Am J Public Health. 2003 Jun; 93(6):919-23.
        View in: PubMed
      84. Turner KR, McFarland W, Kellogg TA, Wong E, Page-Shafer K, Louie B, Dilley J, Kent CK, Klausner J. Incidence and prevalence of herpes simplex virus type 2 infection in persons seeking repeat HIV counseling and testing. Sex Transm Dis. 2003 Apr; 30(4):331-4.
        View in: PubMed
      85. Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, Moss AR. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003 Mar; 80(1):137-46.
        View in: PubMed
      86. Buavirat A, Page-Shafer K, van Griensven GJ, Mandel JS, Evans J, Chuaratanaphong J, Chiamwongpat S, Sacks R, Moss A. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ. 2003 Feb 8; 326(7384):308.
        View in: PubMed
      87. Page-Shafer K, Shiboski CH, Osmond DH, Dilley J, McFarland W, Shiboski SC, Klausner JD, Balls J, Greenspan D, Greenspan JS. Risk of HIV infection attributable to oral sex among men who have sex with men and in the population of men who have sex with men. AIDS. 2002 Nov 22; 16(17):2350-2.
        View in: PubMed
      88. Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, Busch MP, Tobler LH, Phelps B, Moss AR. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis. 2002 Dec 1; 186(11):1558-64.
        View in: PubMed
      89. Fernyak SE, Page-Shafer K, Kellogg TA, McFarland W, Katz MH. Risk behaviors and HIV incidence among repeat testers at publicly funded HIV testing sites in San Francisco. J Acquir Immune Defic Syndr. 2002 Sep 1; 31(1):63-70.
        View in: PubMed
      90. Scheer S, Peterson I, Page-Shafer K, Delgado V, Gleghorn A, Ruiz J, Molitor F, McFarland W, Klausner J. Sexual and drug use behavior among women who have sex with both women and men: results of a population-based survey. Am J Public Health. 2002 Jul; 92(7):1110-2.
        View in: PubMed
      91. Page-Shafer KA, Cahoon-Young B, Klausner JD, Morrow S, Molitor F, Ruiz J, McFarland W. Hepatitis C virus infection in young, low-income women: the role of sexually transmitted infection as a potential cofactor for HCV infection. Am J Public Health. 2002 Apr; 92(4):670-6.
        View in: PubMed
      92. Shugars DC, Sweet SP, Malamud D, Kazmi SH, Page-Shafer K, Challacombe SJ. Saliva and inhibition of HIV-1 infection: molecular mechanisms. Oral Dis. 2002; 8 Suppl 2:169-75.
        View in: PubMed
      93. McCarthy GM, Ssali CS, Bednarsh H, Jorge J, Wangrangsimakul K, Page-Shafer K. Transmission of HIV in the dental clinic and elsewhere. Oral Dis. 2002; 8 Suppl 2:126-35.
        View in: PubMed
      94. Page-Shafer K, Graves A, Kent C, Balls JE, Zapitz VM, Klausner JD. Increased sensitivity of DNA amplification testing for the detection of pharyngeal gonorrhea in men who have sex with men. Clin Infect Dis. 2002 Jan 15; 34(2):173-6.
        View in: PubMed
      95. Turner J, Page-Shafer K, Chin DP, Osmond D, Mossar M, Markstein L, Huitsing J, Barnes S, Clemente V, Chesney M. Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection. AIDS Patient Care STDS. 2001 Dec; 15(12):615-24.
        View in: PubMed
      96. Moon MW, Binson D, Page-Shafer K, Díaz R. Correlates of HIV risk in a random sample of street youths in San Francisco. J Assoc Nurses AIDS Care. 2001 Nov-Dec; 12(6):18-27.
        View in: PubMed
      97. Hahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology. 2001 Jul; 34(1):180-7.
        View in: PubMed
      98. Misegades L, Page-Shafer K, Halperin D, McFarland W. Anal intercourse among young low-income women in California: an overlooked risk factor for HIV? AIDS. 2001 Mar 9; 15(4):534-5.
        View in: PubMed
      99. Greenwood GL, White EW, Page-Shafer K, Bein E, Osmond DH, Paul J, Stall RD. Correlates of heavy substance use among young gay and bisexual men: The San Francisco Young Men's Health Study. Drug Alcohol Depend. 2001 Jan 1; 61(2):105-12.
        View in: PubMed
      100. Rugg DL, Heitgerd JL, Cotton DA, Broyles S, Freeman A, Lopez-Gomez AM, Cotten-Oldenburg NU, Page-Shafer K. CDC HIV prevention indicators: monitoring and evaluating HIV prevention in the USA. AIDS. 2000 Sep 8; 14(13):2003-13.
        View in: PubMed
      101. Page-Shafer K, Kim A, Norton P, Rugg D, Heitgerd J, Katz MH, McFarland W. Evaluating national HIV prevention indicators: a case study in San Francisco. AIDS. 2000 Sep 8; 14(13):2015-26.
        View in: PubMed
      102. Buchacz K, McFarland W, Hernandez M, Klausner JD, Page-Shafer K, Padian N, Molitor F, Ruiz JD, Bolan G, Morrow S, Katz MH. Prevalence and correlates of herpes simplex virus type 2 infection in a population-based survey of young women in low-income neighborhoods of Northern California. The Young Women's Survey Team. Sex Transm Dis. 2000 Aug; 27(7):393-400.
        View in: PubMed
      103. Ruiz JD, Molitor F, McFarland W, Klausner J, Lemp G, Page-Shafer K, Parikh-Patel A, Morrow S, Sun RK. Prevalence of HIV infection, sexually transmitted diseases, and hepatitis and related risk behavior in young women living in low-income neighborhoods of northern California. West J Med. 2000 Jun; 172(6):368-73.
        View in: PubMed
      104. Martin JN, Amad Z, Cossen C, Lam PK, Kedes DH, Page-Shafer KA, Osmond DH, Forghani B. Use of epidemiologically well-defined subjects and existing immunofluorescence assays to calibrate a new enzyme immunoassay for human herpesvirus 8 antibodies. J Clin Microbiol. 2000 Feb; 38(2):696-701.
        View in: PubMed
      105. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med. 1998 Apr 2; 338(14):948-54.
        View in: PubMed
      106. Page-Shafer K, Veugelers PJ, Moss AR, Strathdee S, Kaldor JM, van Griensven GJ. Sexual risk behavior and risk factors for HIV-1 seroconversion in homosexual men participating in the Tricontinental Seroconverter Study, 1982-1994. Am J Epidemiol. 1997 Oct 1; 146(7):531-42.
        View in: PubMed
      107. Veugelers PJ, Kaldor JM, Strathdee SA, Page-Shafer KA, Schechter MT, Coutinho RA, Keet IP, van Griensven GJ. Incidence and prognostic significance of symptomatic primary human immunodeficiency virus type 1 infection in homosexual men. J Infect Dis. 1997 Jul; 176(1):112-7.
        View in: PubMed
      108. Page-Shafer K, Delorenze GN, Satariano WA, Winkelstein W. Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey. Ann Epidemiol. 1996 Sep; 6(5):420-30.
        View in: PubMed
      109. Strathdee SA, Veugelers PJ, Page-Shafer KA, McNulty A, Moss AR, Schechter MT, van Griensven GJ, Coutinho RA. Lack of consistency between five definitions of nonprogression in cohorts of HIV-infected seroconverters. AIDS. 1996 Aug; 10(9):959-65.
        View in: PubMed
      110. Chin DP, Osmond D, Page-Shafer K, Glassroth J, Rosen MJ, Reichman LB, Kvale PA, Wallace JM, Poole WK, Hopewell PC. Reliability of anergy skin testing in persons with HIV infection. The pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med. 1996 Jun; 153(6 Pt 1):1982-4.
        View in: PubMed
      111. Veugelers PJ, Strathdee SA, Moss AR, Page KA, Tindall B, Schechter MT, Coutinho RA, van Griensven GJ. Is the human immunodeficiency virus-related Kaposi's sarcoma epidemic coming to an end? Insights from the Tricontinental Seroconverter Study. Epidemiology. 1995 Jul; 6(4):382-6.
        View in: PubMed
      112. Osmond DH, Page K, Wiley J, Garrett K, Sheppard HW, Moss AR, Schrager L, Winkelstein W. HIV infection in homosexual and bisexual men 18 to 29 years of age: the San Francisco Young Men's Health Study. Am J Public Health. 1994 Dec; 84(12):1933-7.
        View in: PubMed
      113. Veugelers PJ, Page KA, Tindall B, Schechter MT, Moss AR, Winkelstein WW, Cooper DA, Craib KJ, Charlebois E, Coutinho RA, et al. Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. Am J Epidemiol. 1994 Oct 15; 140(8):747-58.
        View in: PubMed
      114. Veugelers PJ, Strathdee SA, Tindall B, Page KA, Moss AR, Schechter MT, Montaner JS, van Griensven GJ. Increasing age is associated with faster progression to neoplasms but not opportunistic infections in HIV-infected homosexual men. AIDS. 1994 Oct; 8(10):1471-5.
        View in: PubMed
      115. Veugelers PJ, Schechter MT, Tindall B, Moss AR, Page KA, Craib KJ, Cooper DA, Coutinho RA, Charlebois E, Winkelstein W, et al. Differences in time from HIV seroconversion to CD4+ lymphocyte end-points and AIDS in cohorts of homosexual men. AIDS. 1993 Oct; 7(10):1325-9.
        View in: PubMed
      116. Lang W, Osmond D, Page-Bodkin K, Moss A, Winkelstein W. Population-based estimates of antiretroviral therapy and anti-Pneumocystis prophylaxis in San Francisco: 1991. J Acquir Immune Defic Syndr. 1993 Feb; 6(2):191-5.
        View in: PubMed
      117. Osmond DH, Charlebois E, Sheppard HW, Page K, Winkelstein W, Moss AR, Reingold A. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis. 1993 Jan; 167(1):66-71.
        View in: PubMed
      118. Page-Bodkin K, Tappero J, Samuel M, Winkelstein W. Kaposi's sarcoma and faecal-oral exposure. Lancet. 1992 Jun 13; 339(8807):1490.
        View in: PubMed
      Kimberly's Networks
      Click the "See All" links for more information and interactive visualizations!
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Same Department
      Back to TOP